Condensed Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2021		47,754,000
Beginning balance at Dec. 31, 2021	$ 381,430	$ 5	$ 566,161	$ (187)	$ (184,549)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		7,000
Issuance of common stock upon exercise of stock options	10		10
Vesting of early exercise options	1		1
Issuance of common stock in public offerings, net of issuance costs (in shares)		1,520,000
Issuance of common stock in public offerings, net of issuance costs	24,103		24,103
Stock-based compensation	6,238		6,238
Net loss	(34,235)				(34,235)
Other comprehensive income (loss)	(1,839)			(1,839)
Ending balance (in shares) at Mar. 31, 2022		49,281,000
Ending balance at Mar. 31, 2022	$ 375,708	$ 5	596,513	(2,026)	(218,784)
Beginning balance (in shares) at Dec. 31, 2022	69,768,000	69,768,000
Beginning balance at Dec. 31, 2022	$ 578,075	$ 7	939,310	(2,698)	(358,544)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)	102,000	102,000
Issuance of common stock upon exercise of stock options	$ 520		520
Issuance of common stock in public offerings, net of issuance costs (in shares)		943,000
Issuance of common stock in public offerings, net of issuance costs	22,441		22,441
Stock-based compensation	9,104		9,104
Net loss	(52,394)				(52,394)
Other comprehensive income (loss)	$ 1,169			1,169
Ending balance (in shares) at Mar. 31, 2023	70,813,000	70,813,000
Ending balance at Mar. 31, 2023	$ 558,915	$ 7	$ 971,375	$ (1,529)	$ (410,938)